Tanvex BioPharma (6541.TW) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.9
-1.68
-1.45
-1.23

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Tanvex BioPharma (6541.TW) will report earnings of for Q2 2024 on May 07, 2024.

0 Comments

Share your thoughts